We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of Concept

This study is currently recruiting participants.
Verified May 2017 by St. Michael's Hospital, Toronto
Sponsor:
ClinicalTrials.gov Identifier:
NCT01752049
First Posted: December 18, 2012
Last Update Posted: May 18, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborators:
University of California, San Francisco
The Hospital for Sick Children
University of Toronto
Sunnybrook Health Sciences Centre
Ryerson University
National Institute of Neurological Disorders and Stroke (NINDS)
Information provided by (Responsible Party):
St. Michael's Hospital, Toronto
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2019
  Estimated Primary Completion Date: June 2019 (Final data collection date for primary outcome measure)